EYEGENE's IPO

EYEGENE raised a round of funding on November 01, 2013. Investors include Public.

EYEGENE (아이진) (KOSDAQ: 185490) is a biotechnology company that develops drugs and vaccines for diabetic retinopathy, pressure ulcer, cervical cancer and other age-related diseases.…

Articles about EYEGENE's IPO: